OMIX

Phase I clinical trial of irinotecan hydrochloride liposome injection combined with 5-FU/LV in the treatment of advanced solid tumors

OMIX002386

1Summary
Title Phase I clinical trial of irinotecan hydrochloride liposome injection combined with 5-FU/LV in the treatment of advanced solid tumors
Description Treatment of advanced solid tumors with irinotecan hydrochloride liposome injection combined with 5-FU/LV
Organism Homo sapiens
Data Type Other Type of Genomic Data
Data Accessibility Controlled-access
BioProject PRJCA012815
Release Date 2023-01-01
Submitter binbin liu (binbin.liu@hengrui.com)
Organization Jiangsu Hengrui Pharmaceutical Co., Ltd
Submission Date 2022-11-18
2Files & Download

The data cannot be downloaded as it has not yet been registered in the Human Genetic Resource Management Platform of MOST.

File ID File Title Number/Samples File Type File Size File Suffix Download Times Download
OMIX002386-01 Genomics data of the project 1 Other Type of Genomic Data 11.5 KB xlsx 0 Unavailable

Request for this Data View All Released Data of OMIX